RLRui Li

Rui Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rui Li has a total of 70 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Brain Iron in Aging Signature Regions Relating to Long‐Term Cognitive Decline in Older Adults

    by Yingzhe Wang, Rui Li, Heyang Lu, Xingdong Chen, Mei Cui

    Background: Brain iron accumulation has been linked to cognitive decline in Alzheimer’s disease (AD), which is often associated with cerebral atrophy in AD‐specific brain regions. However, it remains unclear whether there is a selective pattern of brain iron deposition associated with cognitive aging or age‐related brain atrophy compared to AD. Therefore, this study aimed to investigate the relationship between brain iron level, atrophy, and cognitive decline in a Chinese population‐based cohort and explore the spatial distribution of brain iron deposition associated with individual cognition functions.Method: A total 770 community‐dwelling participants from Taizhou Imaging Study (mean age 62.0 ± 4.93 years, 57.5% women) underwent brain MRI examination, and among them 219 participants accepted neuropsychological tests at a mean follow‐up of 2.68 years. Brain iron deposition was evaluated using quantitative susceptibility mapping (QSM), while global atrophy, cortical thickness and subcortical volumes were analyzed using surface‐based techniques. Global cognition function was assessed using the Mini‐Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA), and domain‐specific cognitive scores were obtained from subscores of MoCA. Regional analyses were performed on the cortical and 3 signature regions: Aging‐specific, Aging and AD signature meta‐ROIs (Figure 1).Result: Iron levels were negatively correlated with classic MRI markers of cortical atrophy (cortical thickness, gray matter volume, local gyrification index) in total, Aging‐specific, and Aging signature cortical regions (all P < 0.05). Participants in the upper tertile of the cortical and Aging‐specific signature QSM showed worse global cognitive function compared to those in the bottom tertile after adjusting for gray matter atrophy. Among 219 participants who underwent follow‐up, higher brain iron levels in all ROIs predicted accelerated deterioration in the rate of cognitive decline in global cognition, attention, and visuospatial function (Table 1 and Table 2, all P < 0.05). These associations remained significant even after the including cortical thickness of each ROI as a covariate.Conclusion: The present study demonstrates that aging and AD‐selective iron deposition is associated with atrophy and cognitive decline in elderly individuals, suggesting the brain iron deposition has the potential to be used as an imaging biomarker for tracking cognitive aging.

  • Open Access

    Inflammatory bowel disease is associated with worse sexual function: a systematic review and meta-analysis

    by Bingliang Chen, Bingyan Zhou, Guoda Song, Hao Li, Rui Li, Zhuo Liu, Chao Wei, Tao Wang, Shaogang Wang, Delin Ma, et al.

    Original Article Inflammatory bowel disease is associated with worse sexual function: a systematic review and meta-analysis Bingliang Chen, Bingyan Zhou, Guoda Song, Hao Li, Rui Li, Zhuo Liu, Chao Wei, Tao Wang, Shaogang Wang, Delin Ma, Jihong Liu, Xiaoyi Yuan, Xiaming Liu


  • Open Access

    Abstract 44: Evolution of large copy number variants in breast cancer through genetic network rewiring

    by Elena Kuzmin, Jean Monlong, Mathieu Bourgey, Jarry Barber, Tom Lesluyes, Toby Baker, Genevieve Morin, Dongmei Zou, Michael Schwartz, Yang Yang, et al.

    Large chromosomal alterations are common in cancer and often show preferential gain or loss across many cancer types indicating their selective advantage. Triple negative breast cancer (TNBC) exhibits complex mutational spectrum without common oncogenic drivers yet displays consistent loss of large chromosomal regions. Here, we characterize selection pressures that maintain a recurrently deleted region of chromosome 4p in TNBC. We used single cell and bulk WGS phylogenetic analysis of TNCB PT/PDX panel to show that chr4p deletion is an early event in tumor evolution. We used scRNAseq gene expression and inferred copy number analysis to show that chr4p loss is associated with a proliferative state. This finding was confirmed by a combination of RNA in situ hybridization and immunofluorescence. We then tested the dosage sensitivity of genes residing within this region by individual and dual overexpression in TNBC PDX-derived cell lines and control normal cell line by assessing their effect on cell proliferation. The overexpression of genes within chr4p elicited a strong cell proliferation defect in cancer but not normal cell line models. We also characterized an unknown gene within chr4p region as a novel member of the STRIPAK complex. Genome-wide pooled ORFeome library screens identified a global pattern of background-specific dosage sensitive regions. Our study shows that large chromosomal deletions are maintained due to evolutionary early genetic network rewiring rendering multiple genes within such regions to be dosage sensitive. Ultimately, this work enhances our understanding of genetic events that modulate TNBC. Citation Format: Elena Kuzmin, Jean Monlong, Mathieu Bourgey, Jarry Barber, Tom Lesluyes, Toby Baker, Genevieve Morin, Dongmei Zou, Michael Schwartz, Yang Yang, Alain Pacis, Constanza Martinez, Hellen Kuasne, Anne-Marie Fortier, Rui Li, Claudia Kleinman, Sidong Huang, Peter van Loo, Quaid Morris, Jiannis Ragoussis, Guillaume Bourque, Morag Park. Evolution of large copy number variants in breast cancer through genetic network rewiring [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 44.

  • Open Access

    Cohort profile: genomic data for 26 622 individuals from the Canadian Longitudinal Study on Aging (CLSA)

    by Vincenzo Forgetta, Rui Li, Corinne Darmond-Zwaig, Alexandre Belisle, Cynthia Balion, Delnaz Roshandel, Christina Wolfson, Guillaume Lettre, Guillaume Pare, Andrew D Paterson, et al.

    Purpose The Canadian Longitudinal Study on Aging (CLSA) Comprehensive cohort was established to provide unique opportunities to study the genetic and environmental contributions to human disease as well as ageing process. The aim of this report was to describe the genomic data included in CLSA. Participants A total of 26 622 individuals from the CLSA Comprehensive cohort of men and women aged 45–85 recruited between 2010 and 2015 underwent genome-wide genotyping of DNA samples collected from blood. Comprehensive quality control metrics were measured for genetic markers and samples, respectively. The genotypes were imputed to the TOPMed reference panel. Sex chromosome abnormalities were identified by copy number profiling. Classical human leukocyte antigen gene haplotypes were imputed at two-field (four-digit). Findings to date Of the 26 622 genotyped participants, 24 655 (92.6%) were identified as having European ancestry. These genomic data were linked to physical, lifestyle, medical, economic, environmental and psychosocial factors collected longitudinally in CLSA. The combined analysis, including CLSA genomic data, uncovered over 100 novel loci associated with key parameters to define glaucoma. The CLSA genomic dataset validated the contribution of a polygenic risk score to screen individuals with high fracture risk. It is also a valuable resource to directly identify common genetic variations associated with conditions related to complex traits. Taking advantage of the comprehensive interview and physical information collected in CLSA, this genomic dataset has been linked to psychosocial factors to investigate both the independent and interactive effects on cardiovascular disease. Future plans The CLSA overall is ongoing. Follow-up data will continue to be collected from participants in the current genomic subcohort, including the DNA methylation and metabolomic data. Ongoing studies focus on elucidating the role of genetic factors in cognitive decline and cardiovascular diseases. This genomic data resource is available on request through the CLSA data access application process.


  • Open Access

    Single-cell sequencing reveals the new existence form of dermal papilla cells in the hair follicle regeneration of cashmere goats

    by Feng Yang, Rui Li, Cun Zhao, Tianyu Che, Juntao Guo, Yuchun Xie, Zhixin Wang, Jinquan Li, Zhihong Liu


  • The complete mitochondrial genome of a threatened loach (Beaufortia kweichowensis) and its phylogeny

    by Zheng-Yong Wen, Bi-Wen Xie, Chuan-Jie Qin, Jun Wang, Deng-Yue Yuan, Rui Li, Yuan-Chao Zou


  • Open Access

    Screening of inherited metabolic abnormalities in 56 children with intractable epilepsy

    by Xiaoming Liu, Rui Li, Shengzhi Chen, Yan Sang, Jiaqiang Zhao

    Epilepsy is a common children's neural disease that is largely controlled by anti-epileptic drugs. Nevertheless, children experience repeated attacks that develop into intractable epilepsy (IE). The aim of the present study was to examine the inherited metabolic abnormalities in children with IE to provide early etiological and symptomatic treatment. Urine and blood samples of 56 children with IE served as the experimental group and 56 cases of children with IE, who were successfully treated served as the control group, and analyzed by gas chromatography-mass spectrometry and tandem mass spectrometry for the metabolic screening of amino, organic, and fatty acids. Urine routine, hepatic function, blood biochemistry, imageology of encephalon and brain stem-evoked potential (auditory and optical) were also examined. Of the 27 IE children confirmed as abnormal in urine and blood screening, there were 19 cases (70.3%) of hypoevolutism or retrogression of intelligence and motor function, 15 cases (55.5%) of brain stem-evoked potential and of encephalic computed tomography (CT) or magnetic resonance imaging (MRI) abnormality, 6 cases (22.2%) of abnormal family history and of abnormal blood biochemistry and blood gas analysis, and 5 cases (18.5%) with skin change and of abnormal hepatic function. Of the 27 cases, 11 cases (19.6%) were diagnosed with inherited metabolic diseases. Among the children in the control group, 3 cases showed abnormal urine test results, one of which had family history, one had hypoevolutism or retrogression of intelligence and motor function, one had brain stem-evoked potential and encephalic CT or MRI abnormality, while two of the 3 cases had inherited metabolic abnormalities. The correlation analysis revealed that abnormal urine test was significantly correlated with inherited metabolic abnormalities (P<0.05). Of the 56 IE patients, 25 cases (44.6%) were identified as abnormal under urine screening, and of the 25 cases, 6 cases had simple generalized seizure (24.0%), 5 cases had simple partial seizure (20.0%), 2 cases had multiple types of seizure (8.0%), and 12 cases had infantile spasms (48.0%). Six cases in the control group showed an abnormal urine test, with 3 cases of simple generalized seizure, 2 cases of simple partial seizure and 1 case of multiple types of seizure. The abnormal urine in infantile spasms was often the risk factor of IE. A total of 46 IE children underwent blood screening and 13 cases were diagnosed as abnormal. In conclusion, inherited metabolic abnormality was a common influential factor in the pathogenesis of IE, especially in infantile spasms. Screening of inborn metabolic abnormality in children with IE should be conducted as early as possible, to achieve early treatment and improve their prognosis.